EXP2549 PUR7776 Hologic Final.pdf

PUR 7776 (Revised 07/2022) Page 1 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.

DESCRIPTION OF INTENDED

SINGLE SOURCE PURCHASE

(PUR 7776)

This description of commodities or contractual services intended for purchase from a single source is posted in accordance with Sections 120.57(3) and 287.057(3), Florida Statutes (F.S.), and will remain posted for a period of at least 15 business days.

Commodity or Contractual Service Required (commodity or United National Standard Products and Services Code (NSPSC), manufacturer, model, and description, as appropriate):

12161500 Indicators and Reagents 41116100 Test kits and quality controls and calibrators and standards

Quantity or Term (as appropriate):

3 years

Requestor (division, bureau, office, individual, as appropriate):

Division of Disease Control and Health Protection, Bureau of Public Health Laboratories (BPHL)

Performance and/or Design Requirements (e.g. intended use, function or application, compatibility, requirements; reference to policy, rule, statute or other act of the Legislature, etc., as appropriate):

The Department’s BPHL has the need to purchase proprietary Aptima HIV-1 Quant Dx testing reagents for the use in the Department’s current HIV testing algorithm.

AGENCY: Florida Department of Health (Department)

TITLE: Hologic, Inc.

Short description of the commodity or services desired: Hologic Aptima HIV-1Quant Dx

CONTACT

Name: Bill Zimmerman Address: 4052 Bald Cypress Way, Tallahassee, FL, 32399 Telephone: (850) 617-5894 Email: Bill.Zimmerman@flhealth.gov

Internal tracking number, if any: EXP2549

Date posted: 3/15/2024 Last day for receipt of information: 4/5/2024

PUR 7776 (Revised 07/2022) Page 2 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.

In accordance with Chapter 60A-1.045,, Florida Administrative Code, the Department requests the authorization to purchase as single source request, the Aptima HIV-1 Quant Dx.

Intended Single Source:

Hologic

Estimated Dollar Amount:

$712,800.00

Justification for single source acquisition (what is necessary and unique about the product, services or source; steps taken to confirm unavailability of competition, as appropriate):

The Aptima HIV-1 Quant Dx assay is the only dual claim assay which is intended to be used as an aid in the diagnosis.

Gen-Probe Sales & Services, Inc. (“Hologic”) is the sole distributor of these kits and reagents. It is in the best interest of the state to maintain continuity by using these specialized kits and reagents to use with the HIV testing algorithm currently used by Department of Health, Division of Disease Control and Health Protection, Bureau of Public Health Laboratories.

Approved By (names & titles, as appropriate, e.g., requestor, requestor management, information systems, budget, purchasing):

Allegra Small, Purchasing Director

Prospective vendors are requested to provide information regarding their ability to supply the commodities or contractual services described. If it is determined in writing by the agency, after reviewing any information received from prospective vendors, that the commodities or contractual services are available only from a single source, the agency shall provide notice of its intended decision to enter a single-source purchase contract in the manner specified in Rule 60A-1.045, Florida Administrative Code, and section 120.57(3), F.S.